Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Dermatology

What Causes LPP? Stress, Hormones, or Autoimmunity?

At a Glance

The exact cause of lichen planopilaris is usually unknown. The condition appears to involve an immune attack on hair follicles, while stress, hormones, autoimmune conditions, genetics, medicines, and environmental exposures are possible associations rather than proven causes.

Lichen planopilaris (LPP) is an immune-mediated condition where the immune system mistakenly targets the body’s own hair follicles. The exact, initial cause of LPP is unknown, but one thing is certain: you did not cause this. It is not the result of poor hygiene, infrequent hair washing, or any personal failing [1][2]. It is also not contagious. Current research points to several possible susceptibility factors—such as genetics and immune system changes—but for most people, no single cause can be identified.

Because LPP can cause permanent scarring, unexplained progressive hair loss with scalp redness, scale, itching, pain, or loss of visible hair follicle openings warrants timely evaluation by a dermatologist. Treatment focuses on stopping or slowing active inflammation to protect follicles that are still healthy; unfortunately, hair from a follicle that is already scarred and destroyed cannot regrow [3].

How LPP Affects the Hair Follicles

Under normal circumstances, hair follicles have immune privilege, meaning they are protected from the body’s immune system. In LPP, the current scientific model suggests this protection may break down [3]. Certain immune cells (specifically T cells and macrophages) accumulate around the upper part of the hair follicle [4][5].

Researchers believe these cells may damage the “bulge” region, which is where crucial hair stem cells live. When these stem cells are injured by inflammation, the follicle loses its ability to regenerate hair and is eventually replaced by scar tissue [3][4]. While we understand this likely sequence of events, researchers still do not know why immune privilege is lost in an individual patient.

Are Autoimmune Conditions to Blame?

Because LPP involves the immune system, it shares characteristics with autoimmune diseases. People with LPP are reported to have higher associations with other immune-mediated conditions in some observational studies. These can include:

  • Thyroid disorders (like hypothyroidism) [6]
  • Systemic lupus erythematosus (SLE) [7][8]
  • Psoriasis and vitiligo [6][8]
  • Rheumatoid arthritis [6]

However, having one of these conditions does not cause LPP, and most people with LPP do not necessarily have a systemic autoimmune disease [6]. Their occasional overlap just suggests that some individuals have a general susceptibility to immune system misdirection. Universal screening for all of these diseases is not automatically indicated for everyone with LPP. Instead, your dermatologist may recommend specific tests (like thyroid checks) guided by your personal symptoms, physical exam, and family history [6].

The Role of Stress and Hormones

Many patients wonder if a highly stressful period or hormonal changes triggered their LPP.

  • Stress: Questionnaire-based studies show an association between LPP and a history of major stressful life events [9]. However, this does not prove that stress causes the condition. Scarring hair loss causes significant psychological distress, making it hard to tell whether stress preceded the disease or resulted from it [10]. Stress management and counseling can support your emotional wellbeing, but they are not a treatment for the immune process itself.
  • Hormones: Some studies have noted an association between LPP and postmenopausal status in women [9]. A related but distinct scarring hair loss condition called frontal fibrosing alopecia (FFA) has shown mixed associations with pregnancy history and hormone replacement therapy [11][12]. However, these observational associations do not establish that hormonal changes or androgen levels cause classic LPP, which can occur at any age and outside the postmenopausal group. Do not stop or change any prescribed hormone therapy without discussing it with your clinician.

Genetics, Medications, and the Environment

Researchers have explored other potential contributors, but the evidence is limited or weak:

  • Genetics: Genetic susceptibility may contribute, but LPP is not a predictably inherited disease, and there is no routine genetic test for it. While specific genetic markers have been noted in small studies [13], familial cases of LPP are rare or incompletely characterized [14]. Having a relative with common, non-scarring hair loss (like male or female pattern baldness) does not by itself establish a meaningful risk for LPP.
  • Medications: In rare, isolated case reports, certain medications (like specific biologics) have been linked to LPP-like hair loss [15][16]. Never stop taking a prescribed medication without speaking to your doctor first, as untreated underlying conditions can be dangerous, and drug-induced LPP is very uncommon.
  • Environmental Factors: Some questionnaire studies report very weak associations between LPP and the use of hair dyes or facial soaps [9]. There are also isolated reports of LPP appearing after scalp trauma (like a hair transplant) [17] or exposure to certain occupational chemicals [18]. These are not proven causes. Ordinary cosmetics and daily hygiene are not established causes of LPP; avoiding a product is mainly reasonable if it actively irritates your scalp.
  • Infections: Studies of the scalp microbiome (bacteria and viruses) are ongoing, but researchers have not found a proven viral or bacterial infection that initiates classic LPP [19][2].

Ultimately, LPP is not something you caused. For most people, no specific cause can be identified; current research points to several possible susceptibility factors and immune mechanisms. Focusing on what you can do—partnering with your dermatologist to monitor and control active inflammation, practicing gentle scalp care, and seeking emotional support—is the most empowering path forward.

Common questions in this guide

What is the most likely cause of lichen planopilaris?
The exact starting cause of lichen planopilaris is usually unknown. Researchers think the immune system may lose some of the hair follicle’s normal protection and attack cells near the follicle, leading to inflammation and scarring. LPP is not caused by poor hygiene, and it is not contagious.
Can stress trigger lichen planopilaris?
Studies have found an association between LPP and major stressful events, but they do not prove that stress starts the disease. Hair loss itself can also cause substantial distress, so the timing can be difficult to interpret. Stress management or counseling may support well-being but does not replace treatment for active inflammation.
Can hormones or menopause cause LPP?
Some studies have reported an association between LPP and being postmenopausal, but this does not establish that hormonal changes or androgen levels cause LPP. LPP can occur at different ages and is distinct from frontal fibrosing alopecia, which has its own mixed hormone-related findings. Do not stop or change prescribed hormone therapy without discussing it with your clinician.
Do autoimmune diseases cause lichen planopilaris?
Thyroid disorders, lupus, psoriasis, vitiligo, and rheumatoid arthritis have been reported more often in some people with LPP, but these associations do not prove that the conditions cause it. Most people with LPP do not necessarily have an autoimmune disease affecting the whole body. A dermatologist may suggest specific testing based on your symptoms, examination, and family history rather than screening everyone.
Can genetics, medicines, hair products, or infections cause LPP?
Some people may have genetic susceptibility, but LPP is not predictably inherited and there is no routine genetic test. Rare medication reports and weak associations with hair products, scalp injury, or chemicals do not prove these are causes, and no bacterial or viral infection has been shown to start classic LPP. Do not stop a prescribed medication without speaking with your doctor.
How can I tell whether my LPP is active?
Active LPP may cause increasing scalp redness, scale, itching, pain, or progressive hair loss, and the openings where hairs normally grow may disappear. A dermatologist can examine your scalp and monitor changes over time to decide whether inflammation is still active. Prompt evaluation matters because hair follicles destroyed by scarring cannot regrow hair.

Get notified when new evidence is published on Lichen planopilaris.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a case series of biphasic clinical presentation and theories on pathogenesis.

    Yip L, Barrett TH, Harries MJ

    Clinical and experimental dermatology 2020; (45(1)):63-72 doi:10.1111/ced.13989.

    PMID: 31017678
  2. 2

    Lichen Planopilaris: The first biopsy layer microbiota inspection.

    Pinto D, Calabrese FM, De Angelis M, et al.

    PloS one 2022; (17(7)):e0269933 doi:10.1371/journal.pone.0269933.

    PMID: 35849580
  3. 3

    Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

    Senna MM, Peterson E, Jozic I, et al.

    JID innovations : skin science from molecules to population health 2022; (2(3)):100113 doi:10.1016/j.xjidi.2022.100113.

    PMID: 35521043
  4. 4

    Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia.

    Chen Q, Li Y, Zhu Q, et al.

    Cell & bioscience 2025; (15(1)):102 doi:10.1186/s13578-025-01447-1.

    PMID: 40671126
  5. 5

    Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases.

    Harries MJ, Jimenez F, Izeta A, et al.

    Trends in molecular medicine 2018; (24(5)):435-448 doi:10.1016/j.molmed.2018.03.007.

    PMID: 29661566
  6. 6

    Comorbidities Associated With Lichen Planopilaris: A Systematic Review and Meta-Analysis.

    Chen LC, Ogbutor C, Bae S, et al.

    International journal of dermatology 2025; (64(12)):2257-2265 doi:10.1111/ijd.17925.

    PMID: 40579650
  7. 7

    Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis.

    Yongpisarn T, Tejapira K, Suchonwanit P

    Frontiers in immunology 2025; (16()):1516407 doi:10.3389/fimmu.2025.1516407.

    PMID: 40948796
  8. 8

    Prevalence and incidence of comorbid diseases and mortality risk associated with lichen planopilaris: a Korean nationwide population-based study.

    Lim SH, Kang H, Heo YW, et al.

    Clinical and experimental dermatology 2023; (48(11)):1230-1237 doi:10.1093/ced/llad235.

    PMID: 37433080
  9. 9

    Evaluation of the Environmental Risk Factors and Comorbidities in Patients with Lichen Planopilaris: A Case-Control Study.

    Mahmoudi F, Moravvej H, Nasiri S, et al.

    Skin appendage disorders 2025; (11(2)):159-165 doi:10.1159/000541295.

    PMID: 40177001
  10. 10

    Stress: an important cofactor in patients with lichen planopilaris and frontal fibrosing alopecia.

    Waśkiel-Burnat A, Starace M, Quadrelli F, et al.

    Postepy dermatologii i alergologii 2026; (43(2)):185-190 doi:10.5114/ada.2026.161197.

    PMID: 42222459
  11. 11

    Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study.

    Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, et al.

    Clinical and experimental dermatology 2019; (44(4)):404-410 doi:10.1111/ced.13785.

    PMID: 30259544
  12. 12

    Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes.

    To D, Beecker J

    Journal of cutaneous medicine and surgery 2018; (22(2)):182-189 doi:10.1177/1203475417736279.

    PMID: 29056083
  13. 13

    Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles.

    Pavlovsky L, Israeli M, Sagy E, et al.

    Acta dermato-venereologica 2015; (95(2)):177-80 doi:10.2340/00015555-1884.

    PMID: 24806356
  14. 14

    Frontal fibrosing alopecia and lichen planopilaris in HLA-identical mother and daughter.

    Rivas MM, Antolín SC, Sambucety PS, et al.

    Indian journal of dermatology, venereology and leprology 2015; (81(2)):162-5 doi:10.4103/0378-6323.152284.

    PMID: 25751333
  15. 15

    Case Report of Lichen Planopilaris Occurring in a Pediatric Patient Receiving a Tumor Necrosis Factor α Inhibitor and a Review of the Literature.

    Jayasekera PS, Walsh ML, Hurrell D, Parslew RA

    Pediatric dermatology 2016; (33(2)):e143-6 doi:10.1111/pde.12768.

    PMID: 26840781
  16. 16

    Lichen planopilaris induced by infliximab: A case report.

    McPhie ML, Wang A, Molin S, Herzinger T

    SAGE open medical case reports 2020; (8()):2050313X20901967 doi:10.1177/2050313X20901967.

    PMID: 32064112
  17. 17

    Lichen Planopilaris After Hair Transplantation and Facial Surgical Procedures: A Systematic Review.

    Lázaro Escudero J, Moon JY, Fiedler J, et al.

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2026; doi:10.1097/DSS.0000000000005244.

    PMID: 42484473
  18. 18

    Development of Lichen Planopilaris-Like Alopecia following Occupational Exposure to Trichloroethylene and Tetrachloroethylene.

    Marks DH, Hagigeorges D, Manatis-Lornell AJ, et al.

    Skin appendage disorders 2019; (5(6)):374-378 doi:10.1159/000501173.

    PMID: 31799267
  19. 19

    Association of Human Herpes Virus 6 Infection with Lichen Planopilaris.

    Balighi K, Daneshpazhooh M, Lajevardi V, et al.

    Mymensingh medical journal : MMJ 2020; (29(4)):977-982.

    PMID: 33116105

This page explains possible contributors to lichen planopilaris for informational purposes only and does not constitute medical advice. Do not stop or change prescription medicines or hormone therapy without speaking with your clinician.